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ABSTRACT 
 
Background: Pneumonia is the leading cause of childhood morbidity and mortality worldwide. Each year, 
approximately 1.6 million children die from pneumonia
. 
According to the estimates of the World Health 
Organization (WHO), pneumonia accounts for almost one-fifth of overall childhood mortality Methods: The study 
was conducted in Department of Paediatric Medicine, SMS Medical College, Jaipur. Study Design: This study is a 
Hospital based analytical type of observational study, Sample size:139 patients. Inclusion criteria: Children 
between 2 months to 18 years admitted with suspicion for pneumonia on the basis of sign and symptoms were 
enrolled. Results: Mean age of study subjects was 3.28 ± 0.62 years with median age was 1.5 years. Out of these, 48 
(34.5%) were female and 91 (65.5%) were male. Majority 75(53.95%) of patients were below 5th centile of their 
weight for age, almost all 138 (99.23%) patients had tachypnoea on clinical examination. According to Chest X-ray 
findings, 97 (69.78%) patients had consolidation, 12 (8.63%) had peribronchial thickening, 7 (5.03%) had pleural 
effusion while 2 (1.43%) had consolidation as well as peribronchial thickening and 8 (5.75%) had both pleural 
effusion and consolidation. On LUS findings on day-1,43 (30.93%) patients had sub pleural lung consolidation, 44 
(31.65%)had confluent B-line with consolidation. 2 (1.43%) had confluent B- Lines with pleural line abnormalities. 
22 (15.82%) had consolidation with pleural line abnormalities. 21 (15.01%) had pleural effusion with consolidation 
while 3 (2.15%) had focal or multiple confluent B-line and only 1 (0.72%) had confluent B-line with pleural 
effusion. 3 (2.15%) patients had no changes in their lung ultrasound. Consolidation was reported in 130 (93.52%) 
patients. LUS characteristic findings reported that 97 (71.3%) patients had involvement of right lung, 26 (19.1%) 
patients had involvement of left lung and 13 (9.6%) had involvement of bilateral lung fields. The two characteristic 
findings common in chest X-ray and LUS are consolidation and pleural effusion. Consolidation was reported in LUS 
findings of 130 (93.53%) patients and chest X-ray findings of 107 (76.97%) patients. this difference was statistically 
significant. Conclusion: Though chest radiograph (CXR) has been considered the 'gold standard for the diagnosis of 
pneumonia in children, Lung ultrasound (LUS) is a very easy and versatile application. It is rapid, portable, 
repeatable, and non-ionizing. 
 
Key words : Bronchopneumonia, Community - acquired pneumonia (CAP),Lung ultrasound (LUS), X-ray chest
Introduction  
Community - acquired pneumonia (CAP) can be 
clinically defined as the presence of signs and 
symptoms of pneumonia (such as fever of >38.5 C, 
cough and respiratory distress) in a previously healthy 
child due to an infection which has been acquired 
outside the hospital[1].. 
______________________________ 
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Pneumonia is the leading cause of childhood morbidity 
and mortality worldwide. Each year, approximately 1.6 
million children die from pneumonia[2].According to 
the estimates of the World Health Organization 
(WHO), pneumonia accounts for almost one-fifth of 
overall childhood mortality[3,4].Early diagnosis and 
management are critical to short- and long-term health 
outcomes. Despite the commonality of pneumonia in 
children, disagreement remains about diagnosis in both 
clinical and research settings[5,6].Many factors 
contribute to these differences, including: health 
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systems resourcing, the number of possible causative 
micro-organisms, host and environmental factors, 
timing of presentation to a health service, expertise of 
the health service providers at various levels of the 
health care system, availability of diagnostic facilities 
and the absence of a true diagnostic gold standard[7,8]. 
The World Health Organization (WHO) 
clinical definition developed for the community setting 
in developing countries is based on the presence of 
cough and tachypnoea [9]. This definition was 
developed particularly with the intention of identifying 
children who had bacterial pneumonia and required 
antibiotics [10] however, while highly sensitive, this 
definition lacks specificity. The major reason for this is 
the problem of viral infections affecting airways but 
not lung parenchyma in children with these 
infections,[11] although many of these children may 
have co-infection particularly with 
Streptococcuspneumoniae .[12] In addition, in settings 
where there is a high prevalence of conditions with 
similar symptoms and signs like malaria and 
tuberculosis (TB), [13, 14], differentiating pneumonia 
from malaria 1 and TB (with human immunodeficiency 
virus) at the time of presentation may be difficult [15]. 
Pneumonia may also be masked in cases of severe 
diarrhoea and hypokalaemia [16]. 
Chest radiograph (CXR) has long been 
considered the 'gold standard for the diagnosis of 
pneumonia in children'. Historically, this has been 
largely driven by the need to identify bacterial 
pneumonia and hence inform the use and choice of 
antibiotic therapy[5]. 
The use of ultrasound for the evaluation of the 
lung is relatively recent. Lung ultrasound (LUS) is a 
very easy and versatile application of echography. It is 
rapid, portable, repeatable, and non-ionizing. The aim 
of this study was to define the ultrasonography 
appearance of pneumonia in children, and to evaluate 
the correlation between clinical and ultrasound findings 
during the course of the disease.  
 
Materials and methods 
 
The study was conducted in Department of 
Paediatric Medicine, SMS Medical College, Jaipur. 
This study is a Hospital based analytical type of 
observational study. Children between 2 months to 18 
years admitted due to clinical suspicion of pneumonia 
on the basis of sign and symptoms were enrolled. 
Cases of pneumonia fulfilling the inclusion and 
exclusion criteria were choosers for the study. 
Sonography machine used HITACHI PRIESVS with 
probe frequency 5-18 MHz. In all patients’ first lung 
ultrasonography examination was performed on the 
day of the admission, defined as day 1, then between 
days 3 and 6, 7 and 10, and 11 and 14. All patients 
were undergo a clinically - driven postero - anterior 
OCR on the day of the admission.  
Written consent were taken from parents or attendants 
of all enrolled children. A predesigned and pretested 
structural Performa was used to collect information. 
Basic demographic data e.g. age, sex, caste, religion, 
parents name and education status, age at diagnosis, 
treatment was collected from all patients. 
Inclusion Criteria 
1. Clinical signs and symptoms suggesting 
pneumonia (cough, tachypnoea, crackle and or 
decreased breath sound, fever with or without 
chills, chest pain). 
2. Children aged ≤ 18 years. 
Exclusion Criteria 
1. Unwilling parents/guardians 
2. Patients with congenital heart disease and /or 
metabolic disorders.  
3. Pre-established cases of pyrexia and cough other 
than pneumonia. 
4. Seriously ill patients with multi organ failure. 
Collecting and interpretation of data 
1. Data were collected with reference to  
a. Clinical examination 
b. Chest X-ray and lung ultra-sonographic findings 
2. After evaluation data were tabulated in 
appropriate manner. 
Data Evaluation: Statistical analysis was done by 
using chi square tests. 
 
Results 
 
In our study a total of 139 children between 2 months 
to 18 years admitted with a clinical suspicion for 
pneumonia on the basis of sign and symptoms were 
enrolled. Following salient observations were made on 
the basis of detailed evaluation. 
 
 
 
 
 
 
 
 
Asian Pac. J. Health Sci., 2017; 4(2):214-223                                          e-ISSN: 2349-0659,   p-ISSN: 2350-0964                         
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________ 
Bhimwal  et al          ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2017; 4(2):214-223 
www.apjhs.com                                    216 
 
Table 1: Baseline characteristics of study subjects 
 
Baseline characteristics No (Percentage) 
Patients, No. (%) 139 (100%)  
Age, mean ± 95%CI,Y  
Median, years 
3.28 ± 0.62  
1.5 
Sex, No. (%)  
Female 
Male 
 
48 (34.5%) 
 91 (65.5%) 
Weight, mean ± 95%CI, kg 
Median, kg 
12.76 ± 1.62 
 9.2 
Geographical distribution, No. (%)  
Rural 
Urban 
Slum  
 
72 (51.79%) 
57 (41.00%) 
10 (7.19%)  
Religion, No. (%)  
Hindu  
Muslim  
 
109 (78.41%)  
30 (21.58%) 
Immunization status, No. (%)  
Complete immunization  
Partial immunization  
Unimmunized 
 
61 (43.88%)  
67 (48.20%)  
11 (7.91%) 
Previous history of hospitalization due to respiratory distress, No. (%) 
Yes 
No 
 
22 (15.82%)  
117(84.17%) 
 
Our study included 139 patients ranging from 2 months 
to 18 years of age. Mean age of study subjects was 3.28 
± 0.62 years with median age was 1.5 years. Out of 
these, 48 (34.5%) were female and 91 (65.5%) were 
male. The mean weight of the patients was 12.76 ± 
1.62 kg and median weight was 9.2 kg. 72 (51.79%) 
were from rural background, 57 (41%) were from 
urban background and 10 (7.19%) belonged to slum 
areas. Out of 139 patients 109 (78.41%) were Hindu 
and 30 (28.51%) were Muslims. In study group, 61 
(43.88%) were fully immunized, 67 (48.2%) were 
partially immunized and 11 (7.91%) were not 
immunized and. 22 (15.82%) had previous history of 
hospitalization due to some respiratory illness. 
Majority 75(53.95%) of patients were below 5th centile 
of their weight for age, 38 (27.33 %) patients were 
between 5
th
 and 25
th
 centile, 20 (14.38%) patients were 
between 25
th
 and 50
th
 centile, 5 (3.59%) patients were 
between 50
th
 and 75
th
 centile, 1 (0.72%) patient were 
between 75
th
  and 90th centile.  There were no Patients 
above 90th centile. In these children cough was 
presenting complaint in 132 (95%), Fever in 125 
(89.9%) and Chest pain in 22 (15.82%) patients. 
 
Table 2: Distribution of patients according to their clinical signs 
 
Respiratory findings No. of patients (%)  n=139  
Tachypnoea 138 (99.23%)  
Nasal flaring 133 (95.68%) 
Use of accessory muscle (chest in drawing) 133 (95.68%) 
Oxygen saturation <90% 12 (8.63%) 
pallor 78 (56.11%)  
 
Almost all 138 (99.23%) patients had tachypnoea on clinical examination. Nasal flaring and use of accessory 
muscles i.e. respiratory distress was present in 133 (95.68%) patients. 12 (8.63%) patients had an oxygen saturation 
of <90%. Pallor was present in 78 (56.11%) patients.  
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Table 3: Distribution of Patients according to auscultatory findings of lungs 
 
Auscultation finding No, of patients (%) N=139 
Crepts 82 (58.09%) 
Wheeze 18 (12.94%) 
Decreased breath sounds 10 (7.19%) 
Crepts + Decreased breath sounds 7 (5.03%) 
Crepts + Wheeze  22 (15.82%)  
 
Out of 139 patients, 82 (58.99%) had Crepts on auscultation. 18 (12.94%) had Wheeze, 10 (7.19%) as decreased 
breath sounds, 7(5.03%) had Crepts as well as decreased breath sounds and 22 (15.82%) had both crepts is and 
wheeze on auscultation.  
 
Table 4: Distribution of patients according to their Total Leukocyte Count 
 
Age group Increased TLC according to age, No. (%)  Total number of patients (%) N=139 
2 months — less than 5 years 59 (60.82%) 97 
5 years — less than 10 years    24 (77.41%) 31 
10 ears — 18 years 9 (81.81%) 11 
 
(Chi-square p=0.1) 
In the age group of 2 months to 5 years, 59 (60.8%) out of 97 patients had leucocytosis. In the age group of years to 
10 years, 24 (77.41%) out of 31 patients had leucocytosis. In the age group of 10 years to 18 years, 9 (81.81%) out 
of 11 patients had leucocytosis. However, the difference between all the three groups is insignificant (p=0.1). 
 
 
Table 5:  Distribution of study subject according to Chest X-ray findings 
 
Chest X-ray findings No. of patients (%)N=139 
Consolidation 97 (69.78%) 
Peribronchial thickening 12 (8.63%) 
Pleural effusion 7 (5.03%) 
Consolidation and peribronchial  thickening 2 (1.43%) 
Pleural effusion and consolidation 8 (5.75%) 
Normal 13 (935%)  
 
According to Chest X-ray findings, out of 139 patients, 97 (69.78%) patients had consolidation, 12 (8.63%) had 
peribronchial thickening, 7 (5.03%) had pleural effusion while 2 (1.43%) had consolidation as well as peribronchial 
thickening and 8 (5.75%) had both pleural effusion and consolidation.  
Out of 139 patients, 13 (9.35%) patients had normal chest X-ray.  
 
Table 6: Distribution of patients according to their LUS findings on day-1 
 
LUS characteristics  No. of patients (%) 
Sub pleural lung consolidation 43 (30.93%) 
Confluent B-lines + consolidation  44 (31.65%) 
Confluent B-line + pleural line abnormalities 2 (1.43%)  
Consolidation + pleural line abnormalities 22 (15.82%)  
Pleural effusion + consolidation 21 (15.10%) 
Focal or multiple confluent B-lines 3 (2.15%)  
Confluent B-lines + Pleural effusion  1 (0.72%)  
Normal 3 (2.15%)  
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Out of 139 patients, 43 (30.93%) patients had sub pleural lung consolidation, 44 (31.65%)had confluent B-line with 
consolidation. 2 (1.43%) had confluent B- Lines with pleural line abnormalities. 22 (15.82%) had consolidation with 
pleural line abnormalities. 21 (15.01%) had pleural effusion with consolidation while 3 (2.15%) had focal or 
multiple confluent B-line and only 1 (0.72%) had confluent B-line with pleural effusion. 3 (2.15%) patients had no 
changes in their lung ultrasound.  
 
Table 7: Follow up of lung consolidation findings as reported by LUS 
 
Maximum thickness of 
consolidation (mm) 
No. of patients (%) 
Day 1 Day 3 - 6 Day 7 - 10 Day 11-14 Total 
Group A(<15) 57 (34.75%) 70 (42.68%)  30 (18.29%)  7 (4.26%) 164 (100%)  
Group B(15-29) 66 (71.73%) 15 (16.3%) 6 (6.52%) 5 (5.43%)  92 (100%) 
Group C(≥30) 7 (50%)  5 (35.71%)  2 (14.28%) 0 (0.0%) 14 (100%) 
Total 130 (93.52%) 90 (64.75%)  38 (27.34%)  12(8.63%)  
 
Consolidation was reported in 130 (93.52%) patients 
out of 139 on LUS on day 1 of Presentation. On 
follow- up studies between day 3 to day 6 of 
presentation, 90 (64.75%) had consolidation, which 
was reduced to 38 (27.34%) on day 7 to day 10 & 12 
(8.63%) on day 11 to 14. These patients were divided 
into three groups according to the maximum thickness 
of consolidation. In group A (patients having 
consolidation of < 15 mm), on day 1, LUS reported 57 
(34.75) patients, which were increased to 70 (42.68%) 
patients on follow-up LUS done on day 3 — day 6 and 
then decreased to 30 (18.29%) patients on follow-up 
LUS done on day 7 — day 10 and to 7 (4.26%) patients 
on follow-up LUS done on day 11— day 14.  
In group B (patients having consolidation of 15 — 29 
mm), there were 66 (71.73%) patients on LUS done on 
day 1, 15 (16.3%) patients on follow-up LUS done 
from day 3 — day 6, 6 (6.52%) patients on follow-up 
LUS done on day 7 — day 10, and 5 (5.43%) patients 
on follow-up LUS done on day 11 to day 14.  
In group C (patients having a consolidation of ≥30 
mm), number of Patients steadily declined on 
subsequent follow-up LUS. On day 1 LUS, 7 (50%) 
patients were reported to be in this group, on LUS done 
on day 3 — day 6, 5 (35.71%) patients, 2 (41.28%) 
patients on day 7 --day 10 and no Patients were 
reported in this group on LUS done on day 11 to day 
14. 
According to LUS characteristics on day 1, a total of 
22 patients had pleural effusion, Out of them, 13 
(59.1%) had a maximum thickness of <15 mm, 8 
(36.4%) patients had a thickness of 15 - 29 mm and 1 
(4.5%) patient had a thickness of > 30 mm. 
Table 8: Follow-up of patients according to pleural effusion as reported by LUS 
 
Maximum thickness of effusion (mm.) No. of patients (%) 
 
Day 1 Day 3-6 Day 7-10 Day 11-14 
 
< 15 13(59.1%) 16(84.2%) 10(90.9%) 2(66.7%) 
15-29 8(36.4%) 2(10.5%) 0(0.0%) 1(33.3%) 
≥ 30 1(4.5%) 1(5.3%) 1(9.1%) 0(0.0%) 
Total 22(15.8%) 19(13.7%) 11(7.9%) 3(2.2%) 
 
19 (13.7%) patients had pleural effusion on follow-up LUS done from day 3-day 6.11 (7.9%) patients had pleural 
effusion on follow-up LUS done from day 7-day 10.3 (2.2%) patients had pleural effusion reported by follow-up 
LUS on day 11- day 14.  
Table 9: Follow-up characteristics of LUS in patients 
 
LUS characteristics 
 
No. of patients (%) 
Day 1 Day 3-6 Day 7-10 Day 11-14 
Confluent B-lines 50 (67.57%) 40(68.96%) 20(62.50%) 8 (57.14%) 
Pleural line 
abnormalities (L-lines) 
24 (32.43%) 18(31.03%) 12 (37.50%) 6 (42.86%) 
Total 74 (53.24%) 58(41.73%) 32(23.02%) 14 (10.07%) 
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LUS on day reported confluent B-lines and pleural line 
abnormalities in 74 (53.24%) patients out of 139. On 
subsequent follow-up LUS done on 3-6 day 7-10 and 
day 11 – 14, 58 (41.73 %), 32 (23.02%) and 14 
(10.07%) patients were reported having confluent B-
line and pleural line abnormalities respectively.  
LUS characteristic findings reported that 97 (71.3%) 
patients had involvement of right lung, 26 (19.1%) 
patients had involvement of left lung and 13 (9.6%) 
Patients had involvement of bilateral lung fields. On 
comparison between right and left lung involvement in 
LUS, the difference is statistically significant (p<0 
001). 
 
Comparison between lung ultrasound and cuest x-ray for the suggestive findings of pneumonia  
Table 10: Comparison of Chest X-ray and LUS characteristic findings for the diagnostic findings of 
pneumonia 
 
 USG Positive  USG negative Total 
Chest X-ray positive 126 (90.64%) 0 126 (90.64%) 
Chest X-ray negative 10 (7.19%) 3 92.16 %) 13 (9.35%) 
Total 136 (97.84%) 3 (2.16%) 139 (100%) 
Chi-square (p=-0.01) 
Among 139 patients having pneumonia, chest X-ray was suggestive of pneumonia in 126 (90.64%) patients while 
LUS was suggestive of pneumonia 136 97.84%) patients. This difference was statistically significant (p=0.01).  
 
Table 11: comparison between LUS and Chest X-Ray findings suggestive of Pneumonia 
 
Characteristics LUS Chest X-Ray p-value 
Consolidation 130 (93.53%0 107 (76.97%) 0.0001 
Plural effusion 22 (15.83%) 15 (5.03%) 0.2 
 
The two characteristic findings common in chest X-ray and LUS are consolidation and pleural effusion. 
Consolidation was reported in LUS findings of 130 (93.53%) patients and chest X-ray findings of 107 (76.97%) 
patients. this difference was statistically significant (p<0.001).  
LUS reported pleural effusion in 22 (15.83%) patients while chest X-ray reported pleural effusion in 15 (5.03%) 
patients. This difference was statistically not significant (p=0.2). 
 
Discussion 
 
Chest radiography has been widely used for 
the diagnosis of pneumonia because of its convenience 
and ease of access. However, substantial variability in 
the interpretation of chest radiographs as well risk of 
the development of cancer after radiation exposure in 
early life. Some studies have focused on the use of 
LUS in the diagnosis and follow up of community-
acquired pneumonia in adults. 
In this study a total of 139 children were enrolled with 
a mean age of 3.28±0.62 yrs and a median age of 1.5 
yrs. The study subjects involved were 48 (34.5%) 
females and 91 (65.5%) males. Mean weight of the 
study subjects was 12.76±1.62 kg and median weight 
was 9.2 kg. Children belong to rural background 72 
(51.79%), urban 57 (41.0%) and slum background l0 
(7.19%). We observed that 109 (78.41%) children were 
Hindu and 30 (21.58%) Muslim. Sixty one (43.9%) 
were fully immunized, 67 (48.2%) were partially 
immunized and 11 (7.91%) were immunized.  
In our study we found that 75 (53.95%) patients weight 
were below 5
th
 centile of their weight for age. 38 
(27.33%) Patients were between 5
th
 and 25
th
 Centile, 20 
(14.38%) Patients were between 25
th
 and 50
th
 centile 
between 50
th
 and 75
th
 centile were 5(3.59%) and 
1(0.72%) patient were between 75
th
 and 90
th
 centile 
weight for age. There were no patients above 90
th
 
centile. We found that 54% of CAP were 
malnourished.  
Rudan et al. (2008) analysed the 28 community based 
longitudinal studies done in developing countries that 
were published between 1969 and 1999 and concluded 
that malnutrition (weight for age <-2 SD ) and LBW 
(≤2.5 kg) is a definitive risk factor for 
pneumonia(17).Salih et al. (2012) studied role of chest 
radiography in diagnosis of pneumonia in 150 subjects 
aged 1-59 months and found malnutrition in 41.4% 
cases of pneumonia(18). Findings of these studies were 
quite similar with our observations. 
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In our study, presenting complaints were cough in 132 
(95%), fever in 125 (89.9%) and chest pain in 22 
(15.82%) children. Juven et al. (2000) studied 
aetiology of community-acquired pneumonia in 254 
hospitalized children and observed that 76.0% had 
cough, 96.0 % had fever and 10.0% had chest pain(19).  
Observation of our study is consistent with that of Shah 
et al. (2013) who studied 209 patients from 0 – 21 
years having clinical suspicion of community -acquired 
pneumonia and found that among the study subjects 
cough was in 81.8% and 73% patients had a history of 
fever[20].In our study on clinical examination out of 
139 study subjects tachypnoea in 138 (99.23%), 
respiratory distress in 133 (95.68%).Observed oxygen 
saturation of < 90% in 12 (8.63%), and pallor in 78 
(56.11%) patients.  Similarly Juven et al. (2000) found 
tachypnoeic was present in 51.0%[19]. 
Elina Lahti et al. (2008)  observed that 36.0% had 
tachypnoea , they observed oxygen saturation of < 90% 
in 4.0%(19) while Shah et al. (2013) studied 209 
patients from 0-21 years having clinical suspicion of 
community acquired pneumonia 26.0% had 
tachypnoea.[20]Difference in our observations might 
be because of the fact we selected subject only on 
clinical ground.  
In our study group signs on auscultation i.e. Crepts, 
wheeze, decreased breath sounds, crepts as well as 
decreased breath sounds and both crepts and wheeze in 
82 (58.99%), 18 (12.94), 10 (7'19%), 7 (5.03%), and 22 
(15.82%) respectively. Similarly Juven et al. (2000) 
observed crackles in 24.0.0%, wheeze in 20.0 %, and 
decreased breath sound was present in 
15.0%.[19]LimaLahti et al. (2008) observed crackles in 
19.0%, decreased breath sound in 27.0 %.[21]. 
According to the leukocyte count, we divided the 
patients in three groups as 2 months to 5 years, 5 to 10 
years and 10 to 18 years. We observed thatleucocytosis 
in group of 2 months to 5 years, 5 to 10 years and 10 to 
18 years 59 (60.8%) out of 97, in 24 (77.41%) out of 
31 and in 9 (81.81%) out of 11 patients respectively.. 
However, the difference between all the three groups is 
insignificant (p=0. 1).  
Chest X-ray findings observed in our study were 
consolidation in97 (69.78%) patients, peribronchial 
thickening in 12 (8.63%), pleural effusion 7 (5.03%), 
while consolidation as well as peribronchial thickening 
in 2 (1.43%) and had both pleural effusion and 
consolidation in 8 (5.75%). Out of 139 patients CXR 
was normal in 13 (9.35%) patients. Similarly Caiulo et 
al. (2012) describe the CXR and ultra-sonographic 
appearance of CAP at presentation and during the 
follow-up. A final diagnosis of pneumonia was 
confirmed in 89/102 patients. In CXR they found 
consolidation in 73/89(82.02%), peribronchial 
thickening in 8/89(8.98%), had pleural effusion in 
3/89(3.37%) and normal x-ray in 8/89(8.98%). [22] 
In our study out of 139 patients on LUS shows sub 
pleural lung consolidation in 43 (30.93%), confluent B-
lines with consolidation in 44 (31.65%), confluent B-
lines with pleural line abnormalities in 2 (1.43%), 
consolidation with pleural line abnormalities in 22 
(15.82%), pleural effusion with consolidation in 21 
(15.10%), focal or multiple confluent B-lines in 3 
(2.15%) and confluent B-lines with pleural effusion in 
1 (0.72%). No changes on their lung ultrasound in 3 
(2.15%).  
Caiulo et al. (2012) found only consolidation in 
13/89(14.60%), consolidation With B-lines in 
55/89(61.79), only B-line in 3/89(3.37%) and normal 
LUS in 12%). Pleural line abnormalities and pleural 
effusion were always associated with areas of confluent 
B-line and/ or lung consolidations. [22] These finding 
were consistent with our study.  
In our study LUS observed consolidation in day one, 
on follow-up or during stay between day 3-6, 7-10, and 
11-14 of illness in 130 (either absolute consolidation 
and/ or with other findings) (93.52%), 90 (64.75%), 38 
(2734%) and 12(8.63%) patients respectively.  
Observations are further analysed and divided into 
three groups according to the maximum thickness of 
consolidation in Group A, Group B and Group C as < 
15 mm, 15 - 29 mm, and ≥30 mm respectively.  
Group A included patients having consolidation of <15 
mm. In this group, LUS reported consolidation on day 
1, day 3 - day 6, day 7 - day 10, and day 11-day 14 in 
57 (34.75%) , 70 (42.68%) (This increase in number is 
due to group B patient falls in this category after 3-4 
day treatment), 30 (18.29 %) and 7 (4.26%) patients 
respectively.  
Group B included patients having consolidation of 15-
29 mm. In this group, LUS reported consolidation on 
day 1, day 3 - day 6, day 7 day 10, and day 11-day 14 
in 66 (71.73%), 15(16 3%), 6 (6.52%) and 5 (5.43%) 
patient respectively.   
Group C include patients having a consolidation of ≥30 
mm. Number of patients in this group steadily declined 
on subsequent follow-up LUS. In this group, LUS 
reported consolidation on day 1 day 3-day 6, day 7, day 
10, and day 11- day 14 in 7(50.0 %), 5(35.71%), 
2(14.2%) and 0 patients respectively.  
Meng-ChiehHo et al. (2014) studied usefulness of LUS 
in the diagnosis of CAP in Children. LUS follow up 
was also performed on 23 patients Day 1, Days 3 to 5, 
and Days 7 to 14. The results showed the decreasing 
size of the pneumonia patch from 10.9± 8.7 cm
2
 to 5.5 
±4.8 cm
2
 and finally to 2± 1.9 cm
2
. This study also 
shows gradual decline in size of consolidation as in our 
results [23]. 
 
Asian Pac. J. Health Sci., 2017; 4(2):214-223                                          e-ISSN: 2349-0659,   p-ISSN: 2350-0964                         
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________ 
Bhimwal  et al          ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2017; 4(2):214-223 
www.apjhs.com                                    221 
 
According to their LUS characteristics out of 130 
patients consolidation thickness < 15 mm in 57 
(43.84%) between 15 - 29 mm in 66 (50.76%), while 
≥30 mm only in 7 (5.38%) as reported on day one. The 
size of consolidation ranges from 5-48 ram with the 
average 16.72 mm. Caiulo et al. (2012) studied LUS 
Characteristics of Community-Acquired Pneumonia in 
Hospitalized Children found lung consolidation of 
mean size 18 mm (range 6-48mm). Our study findings 
also were similar. [22] In our study in seven patient 
initially there is increase in size of consolidation then 
gradual decrease in size of consolidation due change in 
antibiotics. In our study according to LUS 
characteristic on day 1, a total of 22 patients had 
pleural effusion. Out of them, maximum thickness was 
< 15 mm in 13(59.1%), between 15-29 mm in 8 
(36.4%) and ≥30 mm in 1(4.5 %).One thirty nine 
patients underwent LUS and pleural effusion observed 
on day 1, between day 3-6, 7-10 and 11-14 in 22 
(15.8%), 19 (13.7%), 11(7.9%) patients respectively. 
Reissig et al. (2012) the aim of this prospective, 
multicentre study was to define the accuracy of lung 
ultrasound (LUS) in the diagnosis of acquired 
pneumonia (CAP).Three hundred sixty-two patients 
community  with suspected CAP were enrolled in 14 
European centres. During follow-up decreased pleural 
effusion from 50ml to 0 ml[24] 
We also observed decline in size and number of patient 
during follow up.  
In our study LUS 011 day 1 reported confluent B-lines 
and pleural line abnormalities in 74 (53.24%) patients 
out of 139. on subsequent follow-up done on day 3 — 
6, day 7 - 10 and day 11-14, 58 (41.73%), 32 
(23.(02%) and 14 (10.07%) patients were reported 
having confluent B-lines and pleural line abnormalities 
respectively.  
Cauilo et al. (2012). Studied the CXR and ultra-
sonographic appearance of CAP at presentation and 
during the follow-up and observed B-line in 59 patient 
which disappear in follow up and also there were 
disappearance of pleural line abnormalities in follow 
up.[22]Our study shows observation as above study.  
In our study LUS characteristic findings on right side 
in lung 97 (713%), left lung side in 26 (19.10%) and 
bilateral lung fields in 13(9.6%). On comparison 
between right and left lung involvement in LUS, the 
difference is statistically significant (p<0.001). 
MengchiehoHo et al. (2014) retrospective study 
usefulness of lung ultrasound in the diagnosis of CAP 
in children, observed that characteristic location on 
right side in 59.5%, left side in 30.2% and on both side 
in 10.1%. [23] Our findings are similar to above study.  
In our study among 139 patients having pneumonia, 
chest X-ray was suggestive of pneumonia in 126 
(90.64%) patients while LUS was suggestive of 
pneumonia in 136(97.84%) patients with sensitivity 
97.84% and specificity 100%. This difference was 
statistically significant (p=0.01). 
Caitilo et al. (2012) studied the CXR and ultra-
sonographic appearance of CAP at presentation and 
during the follow-up. 89 patients of CAP chest X- ray 
detected pneumonia in 81/89(91.01%) while LUS 
detected pneumonia in 88/89(98.87%)[22]. 
MengchieHo et al. (2014) retrospective study 
usefulness of lung ultrasound in the diagnosis of CAP 
in children, observed that chest X-ray detected 
pneumonia in 152(93.3%) and LUS detect detected 
pneumonia in 159(97.5%). [23] 
Reissing et al. (2012) reported first prospective study in 
adults for the diagnosis of community acquired 
pneumonia using LUS and revealed a sensitivity of 
93.4%, specificity of 97.7% [24].  
These studies show sensitivity and specificity similar to 
our observations. 
In our study the two characteristic findings common in 
chest X-ray and LUS consolidation and pleural 
effusion. Consolidation was reported in LUS findings 
of 130 (93.53%) patients and chest X-ray findings of 
107 (76.97%) patients. This difference was statistically 
significant (p<0.001). LUS reported pleural effusion in 
22 (15.83%) patients while chest X-ray reported 
pleural effusion in 15 (5.03%) patients. This difference 
was statistically not significant (p=0.2).Mengchieho et 
al. (2014) studied the usefulness of lung ultrasound in 
the diagnosis of CAP in children, and found pleural 
effusion in 28.5% in LUS. [23] 
 
Conclusion  
Our study showed a high detection rate for 
LUS in identifying pneumonia in children. It also 
proved to be a promising tool for the follow up of 
patients with pneumonia. Patients can receive more 
frequent follow up using LUS during treatment and 
more information can be made available to 
paediatricians for decision-making. We suggest that 
LUS can be complementary tool to chest radiography 
in the diagnosis of pneumonia in children and follow 
up of these patients by LUS can prevent or reduce the 
exposure to ionizing radiations. 
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